About Cannabix
Cannabix Technologies Inc. is a leader in marijuana breathalyzer development for law enforcement and the workplace. Cannabix is actively developing breath testing technologies in the pursuit of bringing durable, portable tools to market to enhance detection of marijuana impaired driving offences on roads at a time when marijuana is becoming legal in many jurisdictions globally. Cannabix is working to develop drug-testing devices that will detect Tetrahydrocannabinol (THC- the psychoactive component of marijuana that causes intoxication) using breath samples. These devices would be used to provide detection of THC at roadside and identify drivers under the influence of marijuana. In particular, Cannabix is focused on developing breath testing devices for THC detection that would target recent use of THC, (within a two hour time period at time of testing) in contrast to saliva or urine testing for THC which can be invasive and take a considerable amount of time for laboratory analysis. The devices will also be useful for other practical applications such as testing employees in the workplace where intoxication by THC can be hazardous.
The Need for a Solution
Technology
Cannabix Technologies is working with the Yost Research Group at the University of Florida to develop a cutting edge breath detection device based upon high-field ion mobility and mass spectrometry. In particular, Cannabix has an exclusive worldwide license of University of Florida US Patent 8,237,118 in the area of breath analysis of controlled substances.
The Cannabix device would be used to help establish recent use/impairment at roadside. The Yost Research Group is a world leader and pioneer in the development of high-field asymmetric waveform ion mobility spectrometry, known as FAIMS. Cannabix and The Yost Research Group are working together to identify THC in ultra low ranges using highly sensitive FAIMS-mass spectrometer systems (FAIMS-MS).
Cannabix Technologies Inc. is a leader in marijuana breathalyzer development for law enforcement and the workplace. Cannabix is actively developing breath testing technologies in the pursuit of bringing durable, portable tools to market to enhance detection of marijuana impaired driving offences on roads at a time when marijuana is becoming legal in many jurisdictions globally. Cannabix is working to develop drug-testing devices that will detect Tetrahydrocannabinol (THC- the psychoactive component of marijuana that causes intoxication) using breath samples. These devices would be used to provide detection of THC at roadside and identify drivers under the influence of marijuana. In particular, Cannabix is focused on developing breath testing devices for THC detection that would target recent use of THC, (within a two hour time period at time of testing) in contrast to saliva or urine testing for THC which can be invasive and take a considerable amount of time for laboratory analysis. The devices will also be useful for other practical applications such as testing employees in the workplace where intoxication by THC can be hazardous.
The Need for a Solution
- Medical and recreational marijuana use is becoming legal across various jurisdictions in North America and globally. This is presenting a significant challenge to law enforcement to keep our roads safe from drugged drivers.
- Current marijuana enforcement relies on an officer's “opinion” as to the impairment by marijuana – there is a need for a scientific approach that can accurately determine levels present in a non-invasive way.
Technology
Cannabix Technologies is working with the Yost Research Group at the University of Florida to develop a cutting edge breath detection device based upon high-field ion mobility and mass spectrometry. In particular, Cannabix has an exclusive worldwide license of University of Florida US Patent 8,237,118 in the area of breath analysis of controlled substances.
The Cannabix device would be used to help establish recent use/impairment at roadside. The Yost Research Group is a world leader and pioneer in the development of high-field asymmetric waveform ion mobility spectrometry, known as FAIMS. Cannabix and The Yost Research Group are working together to identify THC in ultra low ranges using highly sensitive FAIMS-mass spectrometer systems (FAIMS-MS).
Corporate Video
Disclaimer:
The information in these presentations is historical in nature, has not been updated, and is current only to the date indicated in the particular presentation. This information may no longer be accurate and therefore you should not rely on the information contained in these presentations. To the extent permitted by law, Cannabix Technologies Inc. and its employees, agents and consultants exclude all liability for any loss or damage arising from the use of, or reliance on, any such information, whether or not caused by any negligent act or omission.
The information in these presentations is historical in nature, has not been updated, and is current only to the date indicated in the particular presentation. This information may no longer be accurate and therefore you should not rely on the information contained in these presentations. To the extent permitted by law, Cannabix Technologies Inc. and its employees, agents and consultants exclude all liability for any loss or damage arising from the use of, or reliance on, any such information, whether or not caused by any negligent act or omission.
